Medical News

RSS

Advanced Cell Technology first quarter net loss decreases to $3.3 million

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.

9 May 2011

First Edition: May 9, 2011

"It sounds like a new Apple product, but IPAB is actually a controversial board at the heart of a highly charged battle over Medicare, the federal health program for the elderly and disabled".

9 May 2011

MedCath net revenue increases 0.4% to $97.2 million for second fiscal quarter 2011

MedCath Corporation, a healthcare provider focused on high acuity healthcare services, today announced operating results for its second fiscal quarter ended March 31, 2011. On April 26, 2011, MedCath announced its intention to release the operating results for its second fiscal quarter ended March 31, 2011 on Tuesday, May 10, 2011.

9 May 2011

Covidien completes enrollment in Parietex ProGrip self-fixating mesh study to treat inguinal hernias

Covidien, a leading global provider of healthcare products, today announced that all 600 patients have been enrolled in its clinical study comparing use of Parietex ProGrip self-fixating mesh to the gold-standard suture-based Lichtenstein repair method for primary inguinal hernias.

9 May 2011

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

Lovelace Health System, Inc. has signed a definitive agreement to purchase the assets and operations of the Heart Hospital of New Mexico from MedCath Corporation for $119 million.

9 May 2011

KAEL-GemVax wins European telomerase patent challenge

KAEL-GemVax, a leading oncology biopharmaceutical company, today announced that the recent ruling by the European Patent Office dismissing appeals relating to Geron Corporation's European telomerase patent confirms KAEL-GemVax's patent position on lead product GV-1001, an anti-telomerase vaccine, currently completing the TeloVac Phase III trial for pancreatic cancer.

9 May 2011

IOD announces expanded capabilities to address top health information management challenges

IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, health systems, and physician practices, today announced expanded capabilities to address health information management's top three challenges of this decade: transitioning to ICD-10, implementing electronic records and recruiting highly qualified HIM staff.

9 May 2011

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

Ellman International, Inc., maker of the Pelleve Wrinkle Reduction System, a revolutionary skin tightening system for non-ablative skin rejuvenation, introduced its new family of GlideSafe™ handpieces this week at the American Society for Aesthetic Plastic Surgery's 44th Annual Meeting at the Boston Convention & Exhibition Center.

9 May 2011

New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

A real-world study evaluating the safety of GARDASIL among 189,629 females in California found no serious adverse events related to vaccination, no safety signals for any health event resulting in an emergency room visit or hospitalization and no safety signals associated with pre-specified autoimmune conditions or pregnancy outcomes.

9 May 2011

Illumina announces price reduction in whole human genome sequencing projects

Illumina, Inc. today announced that it is significantly reducing the price for sequencing whole human genomes through the Illumina Genome Network.

From Illumina, Inc. 9 May 2011

GTx reports net loss of $2.6 million for first quarter 2011

GTx, Inc. today provided a company update and reported financial results for the first quarter of 2011.

9 May 2011

Expert says Homeopathy is 'ethically unacceptable'

A bioethics expert from the University of Abertay Dundee has denounced the public funding of homeopathy at a time where Scotland's health budget is under unprecedented pressure.

9 May 2011

Centene's AHCCCS receives Bridgeway contract to deliver Arizona Long Term Care System services

Centene Corporation was notified that the Arizona Health Care Cost Containment System has awarded Bridgeway Health Solutions, Centene's Arizona subsidiary, contracts to deliver Arizona Long Term Care System services.

9 May 2011

caprotec bioanalytics closes Series B financing for EUR 5 million

caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.

9 May 2011

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

OncoSec Medical Inc., a therapeutic oncology company developing innovative medical approaches to treat solid tumor cancers with unmet medical needs, announced today the cancer therapy company's tumor-destroying, tissue-sparing drug/device technology was profiled in Medical Device Daily, the news source for the high-tech medical technology industry that is relied on by thousands of industry insiders every business morning.

9 May 2011

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

Flamel Technologies today announced its financial results for the first quarter of 2011.

9 May 2011

CSEW fails to protect public health by refusing to take part in variant Creutzfeldt-Jakob disease study

The creation of a post-mortem tissue archive for a study of the human form of mad cow disease failed because of a "misguided" refusal by coroners to participate.

9 May 2011

ArtVentive Medical Group performs animal studies treating target vessels with EOS device

ArtVentive Medical Group, Inc. announced today that the Company performed regulatory animal studies treating target vessels with its occlusion system - device. The procedures had a 100% success rate in terms of safety and effectiveness.

9 May 2011

Ideal psychotropic drug may cause physical dependence

A report in the current issue of Psychotherapy and Psychosomatics by a group of European investigators headed by Fabrizio Schifano has explored the potential for dependence of pregabalin using patients' online reports.

9 May 2011

Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe

PharmaEngine, Inc. and Merrimack Pharmaceuticals, Inc. announced today the execution of an agreement under which PharmaEngine grants back to Merrimack the rights to develop, manufacture, and commercialize PEP02 in Asia and Europe, with the exception of Taiwan.

9 May 2011

Medical News

Advanced Cell Technology first quarter net loss decreases to $3.3 million

First Edition: May 9, 2011

MedCath net revenue increases 0.4% to $97.2 million for second fiscal quarter 2011

Covidien completes enrollment in Parietex ProGrip self-fixating mesh study to treat inguinal hernias

Lovelace signs definitive agreement to acquire Heart Hospital of New Mexico

KAEL-GemVax wins European telomerase patent challenge

IOD announces expanded capabilities to address top health information management challenges

Ellman International launches Pelleve GlideSafe handpieces for wrinkle treatment

New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

Illumina announces price reduction in whole human genome sequencing projects

GTx reports net loss of $2.6 million for first quarter 2011

Expert says Homeopathy is 'ethically unacceptable'

Centene's AHCCCS receives Bridgeway contract to deliver Arizona Long Term Care System services

caprotec bioanalytics closes Series B financing for EUR 5 million

OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily

Flamel Technologies total revenues decrease to $6.8 million for first quarter 2011

CSEW fails to protect public health by refusing to take part in variant Creutzfeldt-Jakob disease study

ArtVentive Medical Group performs animal studies treating target vessels with EOS device

Ideal psychotropic drug may cause physical dependence

Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News